← Back to Search

SCH Intervention for Cancer

N/A
Waitlist Available
Led By Kathleen Mooney, PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline then 3 months and 5 months from baseline
Awards & highlights

Study Summary

This study is evaluating whether a home monitoring system can reduce the need for emergency department visits and hospitalizations for cancer symptoms.

Eligible Conditions
  • Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline then 3 months and 5 months from baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline then 3 months and 5 months from baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Health Care Utilization Comparison
Secondary outcome measures
COVID-19 Symptoms, Social distancing and Hygiene Practices
Cancer symptom severity
Impact of Pandemic and Health Related Quality of Life
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: COVID-19 Symptom Augmented SCH InterventionExperimental Treatment1 Intervention
The SCH intervention group will report COVID-19 and cancer-related symptom presence and severity daily into the automated SCH system. Participants receive automated self-management support messages for symptoms reported and a Nurse Practitioner monitors and responds to alerts for COVID-19 symptoms and poorly controlled or worsening cancer symptoms. Participants in this group complete baseline and monthly measures.
Group II: Enhanced Usual CareActive Control1 Intervention
Participants in the control group are given information by research staff reviewing COVID-19 symptoms, home precautions, and instructions on what to do to address concerns that arise. Participants in this group complete baseline and monthly measures.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,095 Previous Clinical Trials
1,775,284 Total Patients Enrolled
Kathleen Mooney, PhDPrincipal InvestigatorUniversity of Utah College of Nursing
1 Previous Clinical Trials
884 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~60 spots leftby Apr 2025